Literature DB >> 30855383

Re-excision Rate after Partial Mastectomy in Oncoplastic Breast-Conserving Surgery: A Single-Institutional Experience and Review of the Literature.

Martin A Benjamin, Catherine Sinnott1, Sheina Bawa1, David I Kaufman2, Katie Guarino1, Tommaso Addona1.   

Abstract

BACKGROUND: Applying oncoplastic techniques to breast conservation therapy is believed to improve cosmetic and oncologic outcomes, compared with standard breast conservation therapy alone. This study aimed to perform a comprehensive review of the literature comparing outcomes of oncoplastic breast conservation therapy (BCT + R) with that of standard breast conservation therapy alone (BCT). A secondary objective was to compare these results to outcomes after oncoplastic breast conservation therapy performed at our institution (BCT + r).
METHODS: A literature search was performed in PubMed using key words, "oncoplastic," "partial breast reconstruction," and "breast conservation therapy." Case reports, case series, and studies with fewer than 10 patients and studies that did not report re-excision rates were excluded. A retrospective chart review was performed from 2011 to 2017 of all cases of oncoplastic breast conservation therapy performed at our institution by a single 2-surgeon team consisting of 1 breast surgeon and 1 plastic surgeon. Outcomes were assessed by comparing re-excision rates between the 3 comparison groups (BCT, BCT + R, BCT + r).
RESULTS: The BCT group was made of 5965 patients (22 articles), and the BCT + R group comprised 2564 patients (41 articles). Re-excision rates in the BCT + R group were lower (4.0%) than the BCT group (17.2%, P = 0.0001). One hundred seventy-two patients comprised the BCT + r group and underwent oncoplastic breast conservation therapy during the study period at our institution. The re-excision rate in the BCT + r group was 1.7% and was significantly lower than the BCT group (P = 0.0001) and lower but not significantly different from the BCT + R group (P = 0.2113).
CONCLUSIONS: Oncoplastic breast conservation therapy leads to lower re-excision rates compared with standard breast conservation therapy. Oncoplastic breast conservation therapy may improve oncologic outcomes compared with standard breast conservation therapy by allowing for more extensive resection without compromising aesthetic results.

Entities:  

Mesh:

Year:  2019        PMID: 30855383     DOI: 10.1097/SAP.0000000000001874

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  5 in total

1.  Performance of standardized tasks and evidence-based surgery may increase the chance of success in breast conserving treatment.

Authors:  Gianluca Franceschini
Journal:  Gland Surg       Date:  2020-08

2.  Oncoplastic surgery: A suitable alternative to conventional breast conserving surgery in low - Middle income countries; a retrospective cohort study.

Authors:  Syeda Sakina Abidi; Lubna Mushtaque Vohra; Muhammad Rizwan Javed; Nargis Khan
Journal:  Ann Med Surg (Lond)       Date:  2021-07-29

3.  Expression of TRPC1 and SBEM protein in breast cancer tissue and its relationship with clinicopathological features and prognosis of patients.

Authors:  Yongqing Zhang; Xiaoqin Lun; Weiling Guo
Journal:  Oncol Lett       Date:  2020-10-29       Impact factor: 2.967

4.  Level II Oncoplastic Surgery as an Alternative Option to Mastectomy with Immediate Breast Reconstruction in the Neoadjuvant Setting: A Multidisciplinary Single Center Experience.

Authors:  Alba Di Leone; Antonio Franco; Daniela Andreina Terribile; Stefano Magno; Alessandra Fabi; Alejandro Martin Sanchez; Sabatino D'Archi; Lorenzo Scardina; Maria Natale; Elena Jane Mason; Federica Murando; Fabio Marazzi; Armando Orlandi; Ida Paris; Giuseppe Visconti; Antonella Palazzo; Valeria Masiello; Liliana Barone Adesi; Marzia Salgarello; Riccardo Masetti; Gianluca Franceschini
Journal:  Cancers (Basel)       Date:  2022-03-01       Impact factor: 6.639

5.  Outcomes of Margin Reexcision after Oncoplastic Breast Reduction.

Authors:  Tasha A Martin; Salman Choudhry; Luther H Holton; W Charles Mylander; Lorraine Tafra; Wen Liang; Rubie Sue Jackson
Journal:  Plast Reconstr Surg Glob Open       Date:  2022-09-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.